Established in June 2022, Coalescence BioPharma, LLC is a premier Biotech Consulting company headquartered in Vestavia, Alabama, USA. We specialize in providing strategic consulting services to Biotech and Pharmaceutical companies, guiding them towards achieving their clinical operations and business development goals.
About The Founder
Dr. Jianwen Zhang, the founder of Coalescence BioPharma, brings a robust background in Preclinical Biology with over 30 years of expertise in the Bio-pharmaceutical industry. His extensive experience spans the spectrum from small molecules to biological drugs, encompassing diverse areas such as anti-viral medications, oncotherapy, and innovative treatments for rare diseases like Hereditary Angioedema (HAE). Dr. Zhang's illustrious career is marked by excellence in various leadership roles, leaving an indelible mark on the field.
Professional Achievements in Biopharma:
2001-2012: Senior Scientist and Study Director of Preclinical Biology at BioCryst Pharmaceuticals Inc. Played a pivotal role in the successful launch of Berotralstat, a groundbreaking drug for treating Hereditary Angioedema (HAE).
2013-2018: Chief Scientist and Business Development Head at KPC Pharmaceuticals, Inc. Demonstrated exemplary leadership by securing over four cross-border partnership projects through license-in, equity investment, and co-development models.
2019-2024: Founder of Coalescence BioPharma and Partner at Angine Biotech in North America. Dr. Zhang contributes to Angine's Global BD business, implementing strategic initiatives in project license-in/out and co-development. His expertise in scientific evaluation, business development, and strategic partnerships significantly enhances these efforts.
